Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

Effects of Repetitive Transcranial Magnetic Stimulation (rTMS)-Primed Self-controlled Practice in People With Parkinson's Disease

Trial N/A Recruiting Sept. 21, 2026

Cognition and Affective Research in China

Trial N/A Not yet recruiting Sept. 21, 2026

Speech Learning and Speech Production in Parkinson's Disease

Trial N/A Recruiting Sept. 21, 2026

Bayesian Optimization of DBS for Gait

Trial Early Phase 1 Recruiting Sept. 21, 2026

This Protocol is a Sub-study Under the PPMI Program. It is a Longitudinal, Single-center Study to Assess the Performance of [18F]AV-133 Imaging Using High and Standard Resolution PET in Individuals Enrolled With Parkinson's Disease (PD) for up to 12 Months.

Trial Phase 2 Recruiting Sept. 20, 2026

MRI-Guided Temporal Interference Stimulation for Parkinson's Disease

Trial N/A Not yet recruiting Sept. 20, 2026

First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD)

Trial Phase 1 Recruiting Sept. 20, 2026

Study to Test Effects and Safety of RO7568282 in Early Parkinson's Disease

Trial Phase 1 Not yet recruiting Sept. 20, 2026

Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease

Trial Phase 2 Recruiting Sept. 20, 2026

The Effects of Ischemic Conditioning in Individuals With Parkinson's Disease

Trial N/A Not yet recruiting Sept. 20, 2026

Blood Flow Restriction Aerobic Exercise for Balance and Anxiety in Parkinson's Disease

Trial N/A Not yet recruiting Sept. 20, 2026

Passive Versus Active Music Therapy Parkinson's Disease

Trial N/A Not yet recruiting Sept. 20, 2026

A Study of Buntanetap in Participants With PD

Trial Phase 2 Recruiting Sept. 20, 2026

ATR 1072 in Participants With PRKAG2 Syndrome

Trial Phase 1 Recruiting Sept. 17, 2026

RESvEraTrol in Parkinson's Disease (RESET)

Trial Phase 2 Recruiting Sept. 17, 2026

PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

Trial Phase 1 Recruiting Sept. 17, 2026

Stimulating Specific Brain Areas (VOP/VIM) With Electricity to Improve Movement and Muscle Control

Trial N/A Recruiting Sept. 17, 2026

Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's Disease

Trial N/A Recruiting Sept. 17, 2026

VisMemoPD Protocol: an Observational Pilot Study on Spatial and Topographical Memory in Patients With Parkinson's Disease and Parkinsonism

Trial N/A Not yet recruiting Sept. 17, 2026

Natural History Protocol for Movement Disorders

Trial N/A Recruiting Sept. 17, 2026